Closed · W81XWH-09-SCIRP-CTA-R · CFDA 12.420 · Discretionary
Spinal Cord Injury Research Program Clinical Trial Award - Rehabilitation
Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- December 10, 2009
- Close date
- 4
- Expected awards
The verdict
Spinal Cord Injury Research Program Clinical Trial Award - Rehabilitation is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 4 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.
- Varies
- award range
- Closed
- application status
- 4
- expected awards
- 12.420
- CFDA program
Archived opportunity record
Spinal Cord Injury Research Program Clinical… is closed (last close December 10, 2009). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed December 10, 2009
Est. Total Funding
$9,600,000
Expected Awards
4
Instrument
Grant
Description
The Clinical Trial Award – Rehabilitation (CTA-R) supports rapid implementation of clinical trials with the potential to have a significant impact on the understanding of SCI and amelioration of its consequences. All studies must be focused on rehabilitative aspects of SCI. All studies must also be applicable to the health care needs of the military service members, their family members, and/or the U.S. veteran population. Funding from this award mechanism cannot be used for preclinical research studies. Principal Investigators (PIs) seeking funding for a preclinical research project should utilize one of the other applicable FY09 SCIRP award mechanisms (for more information about those mechanisms, see http://cdmrp.army.mil). PIs must clearly specify in the Clinical Protocol (main body of the application) which type of clinical trial is being proposed: Phase 0, Phase I, Phase II, Phase III or a combination. For descriptions of each type of clinical trial, please refer to http://www.clinicaltrials.gov and http://www.fda.gov/cder/guidance/6384dft.htm. In addition, refer to the Application Instructions & General Information, Appendix 6, for helpful information about distinguishing clinical trials and clinical research. The proposed clinical trial is expected to begin within 12 months of the award date. CTA-R applications should: Demonstrate availability of, and access to, a suitable patient population that will support a meaningful outcome for the study. Describe clearly defined, focused endpoints for the proposed clinical trial that correspond to the design and sample size proposed. DOD Spinal Cord Injury Clinical Trial Award 4 Clearly articulate the statistical analyses plan. Include a power analysis reflecting sample size projections that will clearly answer the objectives of the study. Discuss the potential impact of the study results for patients with the specified disease/condition. Include a study coordinator who will guide the clinical protocol through Institutional Review Board (IRB), Human Subjects Research Review Board (HSRRB), and other regulatory approval processes; coordinate activities from all sites participating in the trial, and coordinate participant accrual. The clinical trial should have a potentially high impact. The focus must be clearly on SCI rehabilitation. Investigational New Drug (IND) approvals, if applicable, should be initiated or completed before submission to the CTA-R mechanism. If IND/IDE (investigational device exemption) approval is not received by June 30, 2010, the Government reserves the right to revoke funding. Demonstrate institutional support. Multi-institutional Clinical Trials: If the proposed clinical trial is multi-institutional, plans for communication and data transfer between the collaborating institutions, as well as how specimens and/or imaging products obtained during the study will be handled, should be included in the appropriate sections of the Clinical Protocol. A separate intellectual and material property plan agreed upon by all participating institutions is also required for multi-institutional clinical trials. Use of Human Subjects and Human Biological Substances: All Department of Defense (DOD)-funded research involving human subjects and human biological substances must be reviewed and approved by the USAMRMC Office of Research Protections (ORP), Human Research Protection Office (HRPO), in addition to local IRBs. The HRPO is mandated to comply with specific laws and directives governing all research involving human subjects that is conducted or supported by the DOD. These laws and directives are rigorous and detailed, and will require information in addition to that supplied to the local review board. Allow a minimum of 6 months for regulatory review and approval processes for studies involving human subjects. Refer to Application Instructions & General Information, Appendix 6, for detailed information. Encouraged DOD Collaboration and Alignment: Alignment with current DOD research and collaboration with military researchers and clinicians is encouraged. The following websites may be useful in identifying information about ongoing DOD areas of research interest within the FY09 SCIRP Areas of Encouragement: Defense Technical Information Center http://www.dtic.mil Congressionally Directed Medical Research Programs http://cdmrp.army.mil U.S. Army Medical Research and Materiel Command https://mrmc.amedd.army.mil Air Force Research Laboratory http://www.wpafb.af.mil/afrl DOD Spinal Cord Injury Clinical Trial Award 5 Navy and Marine Corps Public Health Center http://www-nehc.med.navy.mil/ U.S. Department of Veterans Affairs, Office of Research and Development www.research.va.gov Office of Naval Research http://www.onr.navy.mil/ U.S. Army Research Laboratory http://www.arl.army.mil U.S. Naval Research Laboratory www.nrl.navy.mil Defense Advanced Research Projects Agency http://www.darpa.mil/ U.S. Army Medical Research Acquisition Activity http://www.usamraa.army.mil Naval Health Research Center http://www.nhrc.navy.mil/ Office of the Under Secretary of Defense for Acquisition, Technology and Logistics http://www.acq.osd.mil/
Catch-all / unrestricted eligibility mark · W81XWH-09-SCIRP-CTA-R
Grants.gov marks Spinal Cord Injury Research Program Clinical… with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).
- Code 99
- Unrestricted / see official listing
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org
More from Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Synergistic Idea Award
DoW Neurofibromatosis Investigator-Initiated Research Award
DoW Neurofibromatosis Research Academy – Scholar Award
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DOW Combat Readiness – Medical Research Program Translational Research Award
What to do next
Spinal Cord Injury Research Program Clinical… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |